[Ip-health] Re: IGWG II: Limitation on Diseases

Wed Nov 7 20:10:04 2007

There are lots of ways that the discussions could be more open.  The
rooms have galleries, which the public could sit in, as is the practice
during the annual WHA meetings.  Technically, they could broadcast the
comments also, even over the Internet.  I guess there is a sense that
having the events somewhat closed make it easier to get the work done.
It is actually more open than are the WTO negotiations, and more open
than many recent WIPO negotiations that have been done informally.  But
for three days NGOs have not been permitted to speak, and we cannot
directly hear the debate at all, having to rely on bits and pieces from
those in the room.  I am grateful to people on government delegations,
including from the US del, which take the time to brief people on
things, or respond to questions about things.

I think the IGWG leadership should allow the public to sit in the
galleries and listen.  Why have people go through accreditation, and
then exclude us from all of the substantive discussions?

If the US State Department has a policy on these things, I don't know
what it is.

  Jamie

On Wed, 2007-11-07 at 09:42 -0500, mko wrote:
> David,

> Ifind your comments surprising.  Surely a State Department employee
> understands the difference between being in the room at the table, and
> hearing from others second hand.
>
> I hope the US delegation is in Geneva at taxpayer expense to represent al=
l
> of the citizens of the US, not just a specific corporate interest.
>
> Kevin Outterson
> Associate Professor of Law
> Boston University
>
> On 11/7/07 6:53 AM, "Hohman, David E" <HohmanDE@state.gov> wrote:
>
> > Then don't complain that you don't have access.
> >
> >
> >
> > -----Original Message-----
> >
> > From: Judit Rius Sanjuan <judit.rius@keionline.org>
> >
> > To: Hohman, David E
> >
> > CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>
> >
> > Sent: Wed Nov 07 12:51:29 2007
> >
> > Subject: Re: [Ip-health] Re: IGWG II: Limitation on Diseases
> >
> >
> >
> > Dear Mr. Hohman,
> >
> >
> >
> > Thank you for your email. In this era of blackberries, sms, email and
> >
> > people going outside of the room to have a coffee, we have access to
> >
> > knowledge.
> >
> >
> >
> > I am sure the 49 pharmaceutical companies representatives are equally
> >
> > well informed, as are biotech who are actually in the room.
> >
> >
> >
> > Judit
> >
> >
> >
> > Hohman, David E wrote:
> >
> >> If you don't have access how do you know it's going on?
> >
> >>
> >
> >> -----Original Message-----
> >
> >> From: ip-health-admin@lists.essential.org
> >> <ip-health-admin@lists.essential.org>
> >
> >> CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>
> >
> >> Sent: Wed Nov 07 12:31:25 2007
> >
> >> Subject: [Ip-health] Re: IGWG II: Limitation on Diseases
> >
> >>
> >
> >> It seems the footnote 1 may be coming back, they are currently
> >
> >> discussing it in one of the drafting rooms we (NGOS) do not have acces=
s to.
> >
> >>
> >
> >> Judit Rius Sanjuan wrote:
> >
> >>
> >
> >>> We have been informed that yesterday night one of the drafting group
> >
> >>> agreed to eliminate the footnote 1 included in the Secretariat Draft
> >
> >>> Global Strategy and Plan of Action.
> >
> >>>
> >
> >>> These are very good news because the footnote 1 included a
> >
> >>> unjustifiable limitation by listing the diseases that will be the
> >
> >>> focus of this global strategy and plan of action:
> >
> >>>
> >
> >>> Footnote eliminated: "The Commission=C2=B9s definitions of Type I, Ty=
pe II
> >
> >>> and Type III diseases, and the specific diseases on which this draft
> >
> >>> strategy focuses, are as follows: Type I diseases are incident in bot=
h
> >
> >>> rich and poor countries, with large numbers of vulnerable populations
> >
> >>> in each. The strategy will focus on the following Type I diseases,
> >
> >>> increasingly prevalent in developing countries: diabetes,
> >
> >>> cardiovascular disease and cancer. Type II diseases are incident in
> >
> >>> both rich and poor countries, but with a substantial proportion of th=
e
> >
> >>> cases in poor countries. For the purposes of the strategy, the focus
> >
> >>> is on HIV/AIDS and tuberculosis. Type III diseases are those that are
> >
> >>> overwhelmingly or exclusively incident in developing countries. For
> >
> >>> the purposes of the strategy, the focus is on the nine neglected
> >
> >>> infectious diseases that disproportionately affect poor and
> >
> >>> marginalized populations prioritized by the UNICEF/UNDP/World Bank/WH=
O
> >
> >>> Special Programme for Research and Training in Tropical Diseases:
> >
> >>> Chagas disease, dengue and dengue haemorrhagic fever, leishmaniasis,
> >
> >>> leprosy, lymphatic filariasis, malaria, onchocerciasis,
> >
> >>> schistosomiasis and human African trypanosomiasis."
> >
> >>>
> >
> >>>
> >
> >>
> >
> >>
> >
> >> --
> >
> >> Judit Rius Sanjuan
> >
> >> Attorney
> >
> >> judit.rius@keionline.org
> >
> >>
> >
> >> Knowledge Ecology International (KEI)
> >
> >> www.keionline.org / www.cptech.org
> >
> >> 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
> >
> >> Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
> >
> >>
> >
> >> _______________________________________________
> >
> >> Ip-health mailing list
> >
> >> Ip-health@lists.essential.org
> >
> >> http://lists.essential.org/mailman/listinfo/ip-health
> >
> >>
> >
> >
> >
> >
> >
> > --
> >
> > Judit Rius Sanjuan
> >
> > Attorney
> >
> > judit.rius@keionline.org
> >
> >
> >
> > Knowledge Ecology International (KEI)
> >
> > www.keionline.org / www.cptech.org
> >
> > 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
> >
> > Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
> >
> >
> >
> > _______________________________________________
> > Ip-health mailing list
> > Ip-health@lists.essential.org
> > http://lists.essential.org/mailman/listinfo/ip-health
>
> Boston University School of Law
> 765 Commonwealth Ave., Boston  MA  02215
> http://ssrn.com/author=3D340746
>
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health
>